Kim So Young, Kim Sung Gyeong, Park Jong Hyock, Park Eun Cheol
Division of Cardiovascular & Rare Diseases, Korean Centers for Disease Control and Prevention, Korea.
J Prev Med Public Health. 2009 Jul;42(4):243-50. doi: 10.3961/jpmph.2009.42.4.243.
The purposes of this study is to estimate the cost of cancer care after its diagnosis and to identify factors that can influence the cost of cancer care.
The study subjects were patients with an initial diagnosis one of four selected tumors and had their first two-years of cancer care at a national cancer center. The data were obtained from medical records and patient surveys. We classified cancer care costs into medical and nonmedical costs, and each cost was analyzed for burden type, medical service, and cancer stage according to cancer types. Factors affecting cancer care costs for the initial phase included demographic variables, socioeconomic status and clinical variables.
Cancer care costs for the initial year following diagnosis were higher than the costs for the following successive year after diagnosis. Lung cancer (25,648,000 won) had higher costs than the other three cancer types. Of the total costs, patent burden was more than 50% and medical costs accounted for more than 60%. Inpatient costs accounted for more than 60% of the medical costs for stomach and liver cancer in the initial phase. Care for late-stage cancer was more expensive than care for early-stage cancer. Nonmedical costs were estimated to be between 4,500,000 to 6,000,000 won with expenses for the caregiver being the highest. The factors affecting cancer care costs were treatment type and cancer stage.
The cancer care costs after diagnosis are substantial and vary by cancer site, cancer stage and treatment type. It is useful for policy makers and researchers to identify tumor-specific medical and nonmedical costs. The effort to reduce cancer costs and early detection for cancer can reduce the burden to society and improve quality of life for the cancer patients.
本研究旨在估算癌症确诊后的治疗费用,并确定可能影响癌症治疗费用的因素。
研究对象为初次诊断患有四种选定肿瘤之一且在国家癌症中心接受头两年癌症治疗的患者。数据来自医疗记录和患者调查。我们将癌症治疗费用分为医疗费用和非医疗费用,并根据癌症类型对每种费用按负担类型、医疗服务和癌症分期进行分析。影响初始阶段癌症治疗费用的因素包括人口统计学变量、社会经济状况和临床变量。
确诊后第一年的癌症治疗费用高于确诊后随后连续年份的费用。肺癌(25,648,000韩元)的费用高于其他三种癌症类型。在总费用中,患者负担超过50%,医疗费用占比超过60%。在初始阶段,胃癌和肝癌的住院费用占医疗费用的60%以上。晚期癌症的治疗比早期癌症的治疗费用更高。非医疗费用估计在4,500,000至6,000,000韩元之间,其中照顾者的费用最高。影响癌症治疗费用的因素是治疗类型和癌症分期。
确诊后的癌症治疗费用很高,且因癌症部位、癌症分期和治疗类型而异。对于政策制定者和研究人员来说,确定特定肿瘤的医疗和非医疗费用很有用。降低癌症费用的努力以及癌症的早期检测可以减轻社会负担并提高癌症患者的生活质量。